Boekhorst Paul Francis Olivier Te - 03 Dec 2025 Form 4/A - Amendment Insider Report for IMMUCELL CORP /DE/ (ICCC)

Role: President and CEO, Director
Signature: /s/ Timothy C. Fiori Attorney-in-Fact
Issuer symbol: ICCC
Transactions as of: 03 Dec 2025
Net transactions value: +$31,528
Form type: 4/A - Amendment
Filing time: 04 Dec 2025, 16:11:39 UTC
Date Of Original Report: 03 Dec 2025
Previous filing: 03 Dec 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
te Boekhorst Paul Francis Olivier	President and CEO, Director	C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND	/s/ Timothy C. Fiori Attorney-in-Fact	04 Dec 2025	0002095704

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICCC	Common Stock $0.10 par value per share	Purchase	$18,152	+3,598	+97%	$5.04	7,306	03 Dec 2025	Direct	F1
transaction	ICCC	Common Stock $0.10 par value per share	Purchase	$13,376	+2,432	+33%	$5.50	9,738	04 Dec 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.
F2	This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.